LCM
FOLD

Landscape Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Landscape Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,346
Closed -$129K – 659
2015
Q4 		$129K Buy
+13,346
New +$120K 0.02% 927

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Landscape Capital Management's FOLD Position: Q1 2016 in Review

Landscape Capital Management sold out of Amicus Therapeutics (FOLD) in Q1 2016, closing a stake of 13,346 shares — an estimated $129K sold.

Landscape Capital Management first reported a position in FOLD in Q4 2015 and held it in 1 quarter. The position peaked at $129K in Q4 2015. 128 funds tracked by Wall St. Rank hold FOLD as of Q1 2016.

  • Landscape Capital Management reported no remaining Amicus Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Landscape Capital Management sold 13,346 Amicus Therapeutics shares in Q1 2016, an estimated $129K.
  • Landscape Capital Management first reported a position in Amicus Therapeutics in Q4 2015 and held it in 1 quarter.
  • Landscape Capital Management's Amicus Therapeutics position peaked at $129K in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.